PDXK 抗体 (AA 51-160)
(1 reference)-
- 抗原 See all PDXK 抗体
- PDXK (Pyridoxal Kinase (PDXK))
-
抗原表位
- AA 51-160
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 多克隆
-
标记
- This PDXK antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA
- 原理
- Mouse polyclonal antibody raised against a partial recombinant PDXK.
- 序列
- HWKGQVLNSD ELQELYEGLR LNNMNKYDYV LTGYTRDKSF LAMVVDIVQE LKQQNPRLVY VCDPVLGDKW DGEGSMYVPE DLLPVYKEKV VPLADIITPN QFEAELLSGR
- 交叉反应
- 人
- 产品特性
- Antibody Reactive Against Recombinant Protein.
- 免疫原
- PDXK (NP_003672, 51 a.a. ~ 160 a.a) partial recombinant protein with GST tag.
- Top Product
- Discover our top product PDXK Primary Antibody
-
anti-Pyridoxal Kinase (PDXK) (AA 29-253) antibody
PDXK 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Pyridoxal Kinase (PDXK) (AA 29-285) antibodyPDXK 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Pyridoxal Kinase (PDXK) (AA 35-251) antibodyPDXK 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Pyridoxal Kinase (PDXK) antibodyPDXK 适用: 人 WB, IHC, IF, IHC (p), FACS 宿主: 小鼠 Monoclonal 5H5 unconjugated
anti-Pyridoxal Kinase (PDXK) (AA 1-312) antibodyPDXK 适用: 人 WB, IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Pyridoxal Kinase (PDXK) (AA 1-312) antibodyPDXK 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 4G6 unconjugated
anti-Pyridoxal Kinase (PDXK) (AA 1-312) antibodyPDXK 适用: 人 WB, IHC (p) 宿主: 小鼠 Monoclonal 1007CT2-1-1 unconjugated
anti-Pyridoxal Kinase (PDXK) antibodyPDXK 适用: 人, 小鼠, 大鼠 WB, IF 宿主: 兔 Polyclonal unconjugated
anti-Pyridoxal Kinase (PDXK) (AA 1-312) antibodyPDXK 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Pyridoxal Kinase (PDXK) (AA 1-312) antibodyPDXK 适用: 人 WB, IF 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- 50 % glycerol
- 注意事项
- Aliquot to avoid repeated freezing and thawing.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
: "Long-term prednisolone treatments increase bioactive vitamin B6 synthesis in vivo." in: The Journal of pharmacology and experimental therapeutics, Vol. 337, Issue 1, pp. 102-9, (2011) (PubMed).
-
: "Long-term prednisolone treatments increase bioactive vitamin B6 synthesis in vivo." in: The Journal of pharmacology and experimental therapeutics, Vol. 337, Issue 1, pp. 102-9, (2011) (PubMed).
-
-
